New AR/VR application empowers students to explore high-demand careers for the 2025–2026 school yearSAN JOSE, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leader in immersive learning, invites educators and edtech innovators to Booth #1948 at ISTELive 25, held June 30–July 2 at the Henry B. González Convention Center. Attendees will experience the preview of the zSpace Career Explorer™ application, a groundbreaking augmented and virtual reality (AR/VR) tool ...

Upfront Gross Proceeds of $5.0 Million, with Up to Approximately $9.8 Million of Additional Gross Proceeds Assuming the Cash Exercise in Full of Private Placement WarrantsWATERTOWN, Mass., June 27, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic rhinosinusitis (CRS), today announced that it has entered into a definitive agreement for the ...

TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today it will issue its financial results for the three and six months ended June 30, 2025 after markets close on: Thursday, August 7, 2025 A conference call to discuss the results will be hosted by the CAPREIT senior management team on: Friday, August 8, 2025 at 9:00 am ET The telephone numbers for the conference call are: Canadian Toll Free: +1 (833) 950-0062Internatio ...

BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pricing of its previously announced underwritten public offering of 6,604,507 shares of its common stock. The total gross proceeds from the offering to the Company are expected to be approximately $85 million. In addition, CorMedix granted the underwriters a 30-day o ...

文章核心观点 - 公司宣布GTX - 102获FDA突破性疗法认定，有望加速治疗安格曼综合征的开发和审查进程，全球3期Aspire研究正在快速招募，Aurora研究预计今年下半年启动 [1][2][3] 药物GTX - 102相关情况 - GTX - 102是一种通过鞘内注射的反义寡核苷酸疗法，旨在抑制UBE3A反义转录本表达，重新激活缺陷蛋白表达 [4] - 已获FDA突破性疗法认定、孤儿药认定、罕见儿科疾病认定和快速通道认定，以及EMA孤儿药认定和PRIME认定 [4] 安格曼综合征相关情况 - 由母系UBE3A基因功能丧失引起，是一种终身神经发育障碍疾病，影响约6万人，常被误诊为自闭症或脑瘫，目前无获批疗法 [5][6] - 会导致认知、运动障碍，平衡问题和癫痫发作，患者需持续护理，无法独立生活，但症状在成年动物模型中可逆转 [6] 公司相关情况 - 是一家生物制药公司，致力于为严重罕见和超罕见遗传病患者提供新疗法，拥有多元化的获批药物和候选治疗产品组合 [7] - 由经验丰富的管理团队领导，策略基于高效的药物开发，目标是尽快为患者提供安全有效的疗法 [8] 研究进展相关情况 - 全球3期Aspire研究于2024年12月开始招募，预计招募约120名4 - 17岁确诊母系UBE3A基因完全缺失的安格曼综合征儿童 [3] - Aurora研究将评估GTX - 102在其他安格曼综合征基因型和年龄段的效果，预计2025年下半年启动 [3] 信息发布相关情况 - 除SEC文件、新闻稿和公开电话会议外，还通过投资者关系网站和社交媒体发布重要信息 [11] - 财务等信息可在投资者关系网站和领英网站获取 [11] 联系方式相关情况 - 投资者联系Joshua Higa，电话+1 - 415 - 475 - 6370，邮箱ir@ultragenyx.com [12] - 媒体联系Joey Fleury，邮箱media@ultragenyx.com [12]

NOVI, Mich., June 27, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM) a global market leader of innovative thermal management and pneumatic comfort technologies, today announced the expansion of its long-standing partnership with DUOMED into France. Building on years of successful collaboration in the Benelux region, this extension marks a strategic milestone as both companies work to deliver advanced patient temperature management technologies to more clinicians and patients across Europe. Under this agre ...

文章核心观点 - 公司推出智能家庭安全系统PLACE，整合多种安全功能，通过零售渠道让消费者更易获取智能家庭安全解决方案 [1][2] 公司介绍 - 公司成立于1974年，是一家科技公司，利用核心竞争力、战略伙伴关系、收购和持续研究在多个领域占据市场领先地位 [7] 产品情况 产品发布 - 公司推出的PLACE智能家庭安全系统可通过全国大型零售商在线和线下购买 [1] 产品功能 - PLACE集成多种安全功能于一体，通过用户友好的移动应用程序控制，可简化家庭安全管理 [2][4] - PLACE基础款Any Space适用于中央生活区，具备智能烟雾和一氧化碳检测、Wi - Fi连接等功能 [3] - 托儿所单元有视频监控摄像头、双向对讲机等功能；车库单元有CO和热量检测等功能；厨房单元有天然气检测和VOC监测功能 [9] 产品技术 - PLACE在产品系列中引入行业首创的低频发声器技术，能提高警报效果，符合新兴安全标准 [5][6] 产品生产 - PLACE系统在密歇根州泽兰市制造，利用公司在高质量消防技术方面的专业知识，产品在美国制造 [4] 产品购买渠道 - PLACE设备可通过www.PlaceHomeSolutions.com购买，Any Space单元也在全国部分零售店有售 [6]

文章核心观点 Aemetis公司获加州空气资源委员会（CARB）批准七条奶牛场沼气池低碳燃料标准（LCFS）临时路径 ，平均碳强度为 -384 ，这将使这些沼气池产生的LCFS信用额度增加约100% ，公司还有多个可再生能源和能效项目在推进 [1][2][3] 公司业务进展 - 公司子公司Aemetis Biogas建造运营的七个奶牛场沼气池获CARB批准LCFS临时路径 ，自2025年1月1日起生效 ，七条获批路径平均碳强度为 -384 ，范围在 -327 至 -419 之间 [1] - 获批七条LCFS路径使这些沼气池产生的LCFS信用额度增加约100% ，公司有11个运营中的沼气池和一个四奶牛场集群沼气池正在建设中 ，还有额外路径申请正在处理 ，预计在今年LCFS监管修正案通过后获批速度会加快 [2] - 新路径2025年1月1日生效 ，使公司能立即获得2025年第一季度生产的可再生天然气增加的LCFS信用额度 [2] 公司项目情况 - 公司可再生能源和能效项目包括新建奶牛场沼气池 ，预计每年产生超100万MMBtu可再生天然气 ；凯斯乙醇厂机械蒸汽再压缩系统 ，预计2026年起每年增加3200万美元现金流 ；河岸碳封存项目 ，每年将140万吨二氧化碳注入地下 ；年产能7800万加仑的可持续航空燃料和可再生柴油厂已获建设空气许可证等关键批准 [3] 公司简介 - Aemetis是一家可再生天然气和可再生燃料公司 ，总部位于加州库比蒂诺 ，专注于创新技术的运营、收购、开发和商业化 ，以替代石油产品并减少温室气体排放 [4] - 公司2006年成立 ，运营并积极扩展加州沼气消化器网络和管道系统 ，将奶牛场废气转化为可再生天然气 ，在加州中央山谷拥有并运营一座年产能6500万加仑的乙醇生产设施 ，在印度东海岸拥有并运营一座年产能8000万加仑的高品质蒸馏生物柴油和精炼甘油生产设施 ，正在加州开发可持续航空燃料和可再生柴油生物精炼厂 [4]

Frøya, 27 June 2025: The annual general meeting of Kaldvík AS was held today on 27 June 2025 at 12:00 hours (CEST) with approximately 61.24% of all shares entitled to vote present either in person or by proxy. A copy of the minutes is attached to this announcement. All resolutions were approved in accordance with the proposal from the board of directors. For further information, please contact:Roy-Tore Rikardsen, CEO: +354 791 0006 (mobile)Robert Robertsson, CFO: +354 843 0086 (mobile) This information is s ...

June 27, 2025 - 1.45 PM CETRegulated information – Contains inside information Arbitral Tribunal acting under ICC Rules of Arbitration issues final award in an arbitration between Agfa-Gevaert and the insolvency receiver of AgfaPhoto GmbH Mortsel, Belgium – June 27, 2025 – 1.45 PM CETAn Arbitral Tribunal acting under the International Chamber of Commerce (ICC) Rules of Arbitration has rendered a final award in the last arbitration proceeding with a possible material impact between Agfa-Gevaert and the i ...